Supplementation with heat-killed EB-AMDK19 counteracts diet-induced overweight in beagles.

Obesity is a major health problem in dogs and is strongly associated with an increased risk of chronic inflammatory and metabolic diseases. The microaerophilic human gut bacterium has been proposed as a potential preventive and therapeutic agent against obesity in both humans and mice; however, the protective effects of human-derived against canine obesity remain unstudied. We previously demonstrated that the heat-killed strain EB-AMDK19 (AMDK19-HK) isolated from the faeces of a healthy Korean exerts similar protective effects as the live bacterium in mice with high-fat-diet (HFD)-induced obesity. Here, we evaluated the effects of AMDK19-HK on body weight, body fat mass, haematological and biochemical parameters, and faecal microbiota composition in beagles fed an HFD for 12 weeks. AMDK19-HK supplementation effectively suppressed body weight increase, body fat deposition and serum triglyceride increase in the canine model; however, no significant changes in the overall haematological and biochemical parameters were observed, reflecting the direct anti-obesity effect of AMDK19-HK. Additionally, 16S rRNA gene sequencing revealed that AMDK19-HK supplementation induced significant changes in the faecal bacterial community, with an increased abundance of and a decreased abundance of . These results suggest that AMDK19-HK can be used as a dietary supplement to counteract diet-induced overweight in dogs.